tiprankstipranks
Trending News
More News >
Biosyent Inc (TSE:RX)
:RX
Canadian Market

Biosyent (RX) Cash flow

Compare
49 Followers

Biosyent Cash Flow

TSE:RX's free cash flow for Q4 2024 was C$2.67M. For the 2024 fiscal year, TSE:RX's free cash flow was decreased by C$-886.91K and operating cash flow was C$2.62M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
C$ 8.66MC$ 5.05MC$ 4.95MC$ 4.67MC$ 6.89M
Investing Cash Flow
C$ 3.29MC$ 883.85KC$ -10.79MC$ -4.84MC$ 3.39M
Financing Cash Flow
C$ -7.83MC$ -5.78MC$ -4.37MC$ -2.08MC$ -3.37M
End Cash Position
C$ 12.11MC$ 7.98MC$ 7.86MC$ 18.04MC$ 20.29M
Free Cash Flow
C$ 3.99MC$ 4.88MC$ 4.43MC$ 4.58MC$ 6.72M
Currency in CAD

Biosyent Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis